You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 143 No. 6, June 1983 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL INVESTIGATIONS
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (160)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Identification of Risk for Renal Insufficiency From Nonsteroidal Anti-inflammatory Drugs

Joseph L. Blackshear, MD; Morris Davidman, MD; M. Thomas Stillman, MD

Arch Intern Med. 1983;143(6):1130-1134.


Abstract

• Risk for renal insufficiency (RI) resulting from nonsteroidal anti-inflammatory drugs (NSAID) exists in cirrhosis with ascites, nephrotic syndrome, decompensated congestive heart failure, and chronic renal disease. We saw seven cases of NSAID RI that demonstrate important additional clinical risk factors. These include advanced age (mean, 76 years), use of diuretic drugs (6/7 patients), and evidence of renal vascular disease as suggested by long-standing hypertension, diabetes, or atherosclerotic cardiovascular disease (7/7 patients). Analysis of past case reports of NSAID RI also showed these features. Treatment of acute gouty arthritis was the most common precipitating event. Evolving NSAID RI was suggested by rising serum urea nitrogen, serum creatinine, and serum potassium levels, and body weight gain associated with low fractional excretion of sodium. We conclude that since NSAID RI is preventable and reversible, it is important to recognize and monitor the conditions of those patients at risk.

(Arch Intern Med 1983;143:1130-1134)



Author Affiliations

From the Department of Internal Medicine (Drs Blackshear, Davidman, and Stillman) and the Divisions of Nephrology (Dr Davidman) and Rheumatology (Dr Stillman), Hennepin County Medical Center; and the University of Minnesota School of Medicine (Drs Davidman and Stillman), Minneapolis.


Footnotes

Accepted for publication Nov 16, 1982.

Reprint requests to the Division of Rheumatology, Department of Internal Medicine, Hennepin County Medical Center, 701 Park Ave S, Minneapolis, MN 66415 (Dr Stillman).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Effects of Celecoxib and Naproxen on Renal Function in the Elderly
Whelton et al.
Arch Intern Med 2000;160:1465-1470.
ABSTRACT | FULL TEXT  

Chronic Renal Insufficiency: A Diagnostic and Therapeutic Approach
Rahman and Smith
Arch Intern Med 1998;158:1743-1752.
ABSTRACT | FULL TEXT  

Renal Failure and Hyperkalemia Associated With Ketorolac Tromethamine
Pearce et al.
Arch Intern Med 1993;153:1000-1002.
ABSTRACT  

latrogenic Renal Disease
Davidman et al.
Arch Intern Med 1991;151:1809-1812.
ABSTRACT  

Nonsteroidal Anti-inflammatory Drugs and the Risk for Chronic Renal Disease
Sandler et al.
ANN INTERN MED 1991;115:165-165.
ABSTRACT  

Nonsteroidal Anti-inflammatory Drug Nephrotoxicity: Should We Be Concerned?
Stillman and Schlesinger
Arch Intern Med 1990;150:268-270.
ABSTRACT  

Naproxen Nephrotoxicity in a 2-Year-Old Child
Ray et al.
Arch Pediatr Adolesc Med 1988;142:524-525.
ABSTRACT  

Ibuprofen-Associated Renal Dysfunction: Pathophysiologic Mechanisms of Acute Renal Failure, Hyperkalemia, Tubular Necrosis, and Proteinuria
Marasco et al.
Arch Intern Med 1987;147:2107-2116.
ABSTRACT  

Salsalate Exacerbation of Chronic Renal Insufficiency: Relation to Inhibition of Prostaglandin Synthesis
Abraham and Stillman
Arch Intern Med 1987;147:1674-1676.
ABSTRACT  

Nephrotoxicity of Common Drugs Used in Clinical Practice
Cooper and Bennett
Arch Intern Med 1987;147:1213-1218.
ABSTRACT  

Cirrhotic Ascites: Pathophysiology, Diagnosis, and Management
ROCCO and WARE
ANN INTERN MED 1986;105:573-585.
ABSTRACT  

Multiple Myeloma
Craig and Powell
Arch Intern Med 1984;144:863-868.
ABSTRACT  

Sulfinpyrazone: Risk for Renal Insufficiency
Boelaert et al.
Arch Intern Med 1984;144:648-648.
ABSTRACT  

Sulfinpyrazone: Risk for Renal Insufficiency-Reply
Blackshear et al.
Arch Intern Med 1984;144:648-649.
ABSTRACT  

Piroxicam and Hyperkalemic Acidosis
GROSSMAN and MOSS
ANN INTERN MED 1983;99:282-282.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1983 American Medical Association. All Rights Reserved.